We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

3 hedge funds and large institutions have $33.4M invested in Plus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $32.1M → $33.4M (+$1.28M)

0% more funds holding

Funds holding: 3 → 3 (0)

70% less call options, than puts

Call options by funds: $164K | Put options by funds: $542K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$164K
Puts
$542K
Net Calls
-$378K
Net Calls Change
+$208K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$143K
2
SIP
Stoneridge Investment Partners
Pennsylvania
-$134K
3
Principal Financial Group
Principal Financial Group
Iowa
-$59K
4
RCM
Rotella Capital Management
Washington
-$48K
5
PC
Passport Capital
California
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$5.96M – – –
BIT
2
BlackRock Institutional Trust
California
$5.09M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.3M – – –
Northern Trust
4
Northern Trust
Illinois
$2.02M – – –
State Street
5
State Street
Massachusetts
$1.98M – – –
PCM
6
Perkins Capital Management
Minnesota
$1.93M – – –
GCM
7
Goldman Capital Management
New York
$897K – – –
Jennison Associates
8
Jennison Associates
New York
$847K – – –
GS
9
Gagnon Securities
New York
$834K – – –
BCM
10
Bridgeway Capital Management
Texas
$726K – – –
PCMI
11
Princeton Capital Management Inc
New Jersey
$714K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$684K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$626K – – –
TCIM
14
TIAA CREF Investment Management
New York
$592K – – –
Allianz Asset Management
15
Allianz Asset Management
Germany
$446K – – –
BIM
16
BlackRock Investment Management
Delaware
$438K – – –
Morgan Stanley
17
Morgan Stanley
New York
$360K – – –
CB
18
Commerce Bank
Missouri
$322K – – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$295K – – –
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$291K – – –
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$265K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$246K – – –
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$237K – – –
TA
24
Teachers Advisors
New York
$205K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$194K – – –
1
2 3 4

PSTV Hedge Fund Activity: Q3 2013 in Review

3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2013, worth a combined $33.4M — up 4% from $32.1M a quarter earlier.

Fund positioning in PSTV was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $143K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $33.4M of Plus Therapeutics stock for Q3 2013, up 4% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q3 2013 and 0 closed out.
  • The largest Plus Therapeutics seller in Q3 2013 was Gilder Gagnon Howe & Co, an estimated $143K sold.

Based on aggregated 13F filings for Q3 2013.